Try the Endole App   Research Unlimited Companies, Access Shareholders, Full Financials, Credit History and more in the Endole AppLEARN MORE

Norgine Pharmaceuticals Limited

Norgine House Widewater Place, Moorhall Road, Harefield, Uxbridge UB9 6NS

Overview

WATCH
CUSTOMISE TILES
Key Data
Norgine Pharmaceuticals Limited is an active company incorporated on 13 March 1998 with the registered office located in Uxbridge, Greater London. Norgine Pharmaceuticals Limited has been running for 26 years. There are currently 3 active directors according to the latest confirmation statement submitted on 13th March 2024.
BUY A REPORT
Name
Norgine Pharmaceuticals Limited
Status
ACTIVE
Active since 25 years ago
Confirmation
Submitted
Last submitted on 13 March 2024 (16 days ago)
Next confirmation dated 13 March 2025
Due by 27 March 2025 (11 months remaining)
Last change occurred 7 years ago
Accounts
Submitted
Last accounts submitted for period 31 December 2022 (1 year 2 months ago)
Accounts type was Full Accounts
Next accounts dated 31 December 2023
Due by 30 September 2024 (6 months remaining)
Company No.
03527131
Private Limited Company with Share Capital
Incorporation
13 March 1998
Incorporated 26 years ago
Size
Large
More than 250 employees or over £50 million turnover
Activity
Sale and distribution of pharmaceutical products to the uk market.
Contact
Registered AddressNorgine House Widewater Place
Moorhall Road
Harefield
Uxbridge UB9 6NS
Country OriginUnited Kingdom
TelephoneBuy a Report or Upgrade
Email AddressBuy a Report or Upgrade
WebsiteNorgine.com
Social
UPDATE INFO
VIEW PEOPLE & CONTACTS
People24
British • Director • Chief Legal Officer • Born in Jun 1959
ACTIVE
British • Director • Born in Jan 1978
ACTIVE
Brazilian • Director • Born in Dec 1972
ACTIVE
Abogado Custodians Limited
British • Director
RESIGNED
Abogado Nominees Limited
British • Secretary
RESIGNED
VIEW PEOPLE & CONTACTS
Mutual Companies
Latest Activity
No activity available.
ADD TO WATCH LIST

Norgine Pharmaceuticals Limited

Comprehensive Business Report

  • What's included in this report?
  • Credit Scores & Limits
  • CCJ's, Gazette Notices & Charges
  • All Director and Secretaries Information
  • 5 Year Financial Accounts
  • Shareholders & Group Structure
  • Contact Data & Trading Addresses
  • 7 Day Money Back Guarantee
  • Includes Downloadable Report [View Sample]
Financials
Net Assets, Total Assets & Total Liabilities (2006 - 2022)
Year EndedDec 2022
Total Assets£33.85m
-£5.67m (-14.34%)
vs previous year
Total Liabilities£-15.14m
+£7.21m (+32.25%)
vs previous year
Net Assets£18.71m
+£1.54m (+8.96%)
vs previous year
Cash in Bank£3.75m
-£1.72m (-31.49%)
vs previous year
Employees55
-8 (-12.7%)
vs previous year
Turnover £63.72m
+£3.79m (+6.32%)
vs previous year
Debt Ratio (%)44.72%
-11.82 (-20.91%)
vs previous year
VIEW FINANCIALS
Watch List

Stay updated with Norgine Pharmaceuticals Limited

Monitor changes to this company's activity with instant email notifications.
ADD TO WATCH LIST

Upgrade to view Credit Score and Limit

Access unlimited, real-time insights for any UK company — including 10 Years Financials, Credit Profiles, Owner Structures, and more on–demandPLANS & PRICING
Credit Score and Limit
Current ScoreBuy a Report or Upgrade
Previous ScoreBuy a Report or Upgrade
Endole Credit LimitBuy a Report or Upgrade
Adverse InfoBuy a Report or Upgrade
VIEW CREDIT RISK

Upgrade to view Shareholders

Access unlimited, real-time insights for any UK company — including 10 Years Financials, Credit Profiles, Owner Structures, and more on–demandPLANS & PRICING
Shareholders
VIEW CONTROL & OWNERSHIP

Upgrade to view Group Structure

Access unlimited, real-time insights for any UK company — including 10 Years Financials, Credit Profiles, Owner Structures, and more on–demandPLANS & PRICING
Group Structure
Subsidiaries
VIEW GROUP STRUCTURE
Documents178
Confirmation statement
22 Mar 2024 • 3 Pages
VIEW PDF
Termination of appointment
2 Jan 2024 • 1 Page
VIEW PDF
Appointment
2 Jan 2024 • 2 Pages
VIEW PDF
Full accounts
6 Oct 2023 • 36 Pages
VIEW PDF
Termination of appointment
15 May 2023 • 1 Page
VIEW PDF
VIEW DOCUMENTS